Among these, phosphorylated tau 217 (p‐tau217) has shown greater accuracy than other p‐tau markers, such as plasma and CSF p‐tau181, in differentiating AD from elderly controls and other neurodegenerative disorders.12 The gene discussed is MAPT; the disease is Alzheimer disease.